Deals of the day-Mergers and acquisitions

Reuters04-07
Deals of the day-Mergers and acquisitions

Adds Evotec, Gilead, Senior Plc; Updates Pershing Square

April 7 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday:

** German biotech company Evotec <EVTG.DE> is to receive around $100 million upfront following the closing of the sale of private Germany-based Tubulis to Gilead, the company said on Tuesday.

nTUCC9ZMB2

** Gilead <GILD.O> said on Tuesday it would acquire private Germany-based Tubulis GmbH for up to $5 billion, as the U.S. drugmaker looks to boost its pipeline with a lucrative class of experimental cancer drugs referred to as "guided missiles".

nL4N40Q0UL

** Senior Plc <SNR.L> on Tuesday said it had agreed to a takeover proposal from a consortium comprising investment firms Tinicum and Blackstone <BX.N>, valuing the British aerospace and defence supplier at 1.4 billion pounds ($1.85 billion).

nL4N40Q0UP

** Bill Ackman's Pershing Square <PSHP.L> proposed a deal on Tuesday to merge Universal Music Group <UMG.AS> with its investment fund under a plan to revive the world's biggest music label's value with a listing in the United States.

nL6N40Q0JZ

** Dutch lender ING <INGA.AS> said it had terminated the agreement to sell its Russian business to Moscow-based Global Development JSC, announced in January 2025.

nL6N40Q0DC

(Compiled by Rajarshi Roy and Pranav Mathur in Bengaluru)

((Rajarshi.Roy@thomsoreuters.com))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment